These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17267327)

  • 21. Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.
    Shariat SF; Ashfaq R; Karakiewicz PI; Saeedi O; Sagalowsky AI; Lotan Y
    Cancer; 2007 Mar; 109(6):1106-13. PubMed ID: 17311310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract.
    Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E
    Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
    Tilki D; Reich O; Svatek RS; Karakiewicz PI; Kassouf W; Novara G; Ficarra V; Chade DC; Fritsche HM; Gerwens N; Izawa JI; Lerner SP; Schoenberg M; Stief CG; Skinner E; Lotan Y; Sagalowsky AI; Shariat SF
    J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancer.
    Bertz S; Otto W; Denzinger S; Wieland WF; Burger M; Stöhr R; Link S; Hofstädter F; Hartmann A
    Eur Urol; 2014 Jan; 65(1):218-26. PubMed ID: 22633802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
    Shariat SF; Svatek RS; Tilki D; Skinner E; Karakiewicz PI; Capitanio U; Bastian PJ; Volkmer BG; Kassouf W; Novara G; Fritsche HM; Izawa JI; Ficarra V; Lerner SP; Sagalowsky AI; Schoenberg MP; Kamat AM; Dinney CP; Lotan Y; Marberger MJ; Fradet Y
    BJU Int; 2010 May; 105(10):1402-12. PubMed ID: 20132195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: oncological outcomes.
    Djaladat H; Mitra AP; Miranda G; Skinner EC; Daneshmand S
    Int J Urol; 2013 Dec; 20(12):1229-33. PubMed ID: 23521752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy.
    Horikawa Y; Kumazawa T; Narita S; Inoue T; Yuasa T; Matsuura S; Nanjo H; Satoh S; Tsuchiya N; Habuchi T
    Int J Clin Oncol; 2007 Apr; 12(2):131-6. PubMed ID: 17443281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder.
    Kassouf W; Svatek RS; Shariat SF; Novara G; Lerner SP; Fradet Y; Bastian PJ; Aprikian A; Karakiewicz PI; Fritsche HM; Dinney CP; Tilki D; Kamat AM; Izawa JI; Ficarra V; Lotan Y; Sagalowsky AI; Schoenberg MP; Skinner EC
    Urol Oncol; 2013 May; 31(4):480-6. PubMed ID: 21478035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
    Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
    Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
    Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H
    Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of apoptotic cell death in bladder cancer: a tissue microarray study on 179 urothelial carcinomas from cystectomy specimens.
    Karamitopoulou E; Rentsch CA; Markwalder R; Vallan C; Thalmann GN; Brunner T
    Pathology; 2010 Jan; 42(1):37-42. PubMed ID: 20025478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy.
    Weiss C; von Römer F; Capalbo G; Ott OJ; Wittlinger M; Krause SF; Sauer R; Rödel C; Rödel F
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1455-60. PubMed ID: 19231102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.
    Nuhn P; Bastian PJ; Novara G; Svatek RS; Karakiewicz PI; Skinner E; Fradet Y; Izawa JI; Kassouf W; Montorsi F; Müller SC; Fritsche HM; Sonpavde G; Tilki D; Isbarn H; Ficarra V; Dinney CP; Shariat SF
    Urol Int; 2011; 87(1):42-8. PubMed ID: 21659717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of cell cycle-associated proteins in non-muscle-invasive bladder cancer: correlation with intravesical recurrence following transurethral resection.
    Behnsawy HM; Miyake H; Abdalla MA; Sayed MA; Ahmed Ael-F; Fujisawa M
    Urol Oncol; 2011; 29(5):495-501. PubMed ID: 19914103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy.
    Zehnder P; Moltzahn F; Daneshmand S; Leahy M; Cai J; Miranda G; Bartsch G; Mitra AP; Skinner DG; Skinner EC; Gill IS
    BJU Int; 2014 Jan; 113(1):65-9. PubMed ID: 23937628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy.
    Rink M; Park K; Volkmer BG; Xylinas E; Hansen J; Cha EK; Robinson BD; Hautmann R; Küfer R; Engel O; Chun FK; Dahlem R; Rubin MA; Shariat SF; Mosquera JM
    Urol Oncol; 2013 Nov; 31(8):1716-24. PubMed ID: 22944196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Kluth LA; Xylinas E; Rieken M; El Ghouayel M; Sun M; Karakiewicz PI; Lotan Y; Chun FK; Boorjian SA; Lee RK; Briganti A; Rouprêt M; Fisch M; Scherr DS; Shariat SF
    BJU Int; 2014 Mar; 113(3):393-8. PubMed ID: 24053618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.